ValeurQ4, 24Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26TTMFrais de vente, généraux et administratifs746.8 M758.8 M814.8 M811.4 M872.2 M849.9 M3.35 BRecherche et développement108.5 M110.6 M113.3 M115.9 M118.7 M103.4 M451.3 MRésultat d'exploitation389 M292.3 M300 M351.3 M154.5 M373.2 M1.18 BTotal des produits hors exploitation-47 M4.3 M10.7 M-7.8 M4.1 M-8.1 M-1.1 MCharges d'intérêts, nettes des intérêts capitalisés———————Résultat hors exploitation, hors charges d'intérêts-8.9 M1.4 M6.8 M-11.1 M-11.3 M-5.1 M-20.7 MRevenus/dépenses exceptionnels-38.1 M2.9 M3.9 M3.3 M15.4 M-3 M19.6 MRésultat avant impôts289 M229 M224.6 M279.2 M98 M301.3 M903.1 MPart des actionnaires dans le résultat———————Impôts48.9 M46.5 M71.2 M48 M-40 M63 M142.2 MIntérêts ne donnant pas le contrôle / intérêts minoritaires———————Autres produits/charges après impôts———————Résultat net avant activités abandonnées239.5 M182 M152.8 M230.9 M139.4 M238.1 M761.2 MActivités abandonnées0——————Résultat net239.5 M182 M152.8 M230.9 M139.4 M238.1 M761.2 MAjustement de dilution———————Dividendes privilégiés———————Résultat net dilué revenant aux actionnaires ordinaires239.5 M182 M152.8 M230.9 M139.4 M238.1 M761.2 MBénéfice par action de base (BPA de base)1.20.920.771.170.71.223.86Bénéfice par action dilué (BPA dilué)1.180.910.771.160.711.223.86Nombre moyen d'actions de base en circulation203.1 M198.9 M197.9 M198.1 M198 M195 M—Nombre d'actions en circulation après dilution203.9 M199.7 M198.3 M198.8 M198.7 M195.8 M—EBITDA714.4 M612.9 M492.5 M559.5 M366.6 M574.4 M1.99 BEBIT327.2 M226.1 M220.7 M275.9 M82.6 M304.4 M883.6 MCoût des ventes586.7 M549.8 M592.2 M559.3 M792.4 M576.2 M2.52 BAutres coûts des ventes———————Amortissements (flux de trésorerie)263.6 M254.4 M271.8 M283.6 M284 M270 M1.11 B
Zimmer Biomet Holdings, Inc. Common Stock
Zimmer Biomet Holdings, Inc. is a publicly traded American medical device company. It was founded in 1927 to produce aluminum splints. The firm is headquartered in Warsaw, Indiana, where it is part of the medical devices business cluster.
In 2001, Zimmer was spun off from Bristol Myers Squibb and began trading on the New York Stock Exchange, on August 7, under the ticker symbol “ZMH”. In November 2011, the company acquired ExtraOrtho, Inc. In January 2012, the company acquired Reno, Nevada-based Synvasive Technology, Inc. On June 29, 2015, the company changed the ticker symbol to "ZBH" to reflect its acquisition of Biomet.
On January 12, 2017, Zimmer Biomet announced a resolution with the DOJ and the SEC in which it agreed to pay a fine of approximately $30.5 million, an amount which would not affect its 2017 outlook.